Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dufay

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Neurologique|April 25, 2018
Organization of care for multiple sclerosis in FranceN Derache, A Dufay, C Lebarbey
Annales De Cardiologie Et D'Angeiologie|May 30, 2018
The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in FranceA Dufay, A Gallo, O Hanon, et al.
Annales De Cardiologie Et D'Angeiologie|November 4, 2017
[Ischemic stroke related to spontaneous]H Benamer, M A Bouzid, A Dufay, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2013
Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft lossM Giral, Y Foucher, A Dufay, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Neurologique|April 25, 2018
Organization of care for multiple sclerosis in FranceN Derache, A Dufay, C Lebarbey
Annales De Cardiologie Et D'Angeiologie|May 30, 2018
The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in FranceA Dufay, A Gallo, O Hanon, et al.
Annales De Cardiologie Et D'Angeiologie|November 4, 2017
[Ischemic stroke related to spontaneous]H Benamer, M A Bouzid, A Dufay, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2013
Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft lossM Giral, Y Foucher, A Dufay, et al.
Pageof 1